In part 3 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the personalization of medicine as the future of diabetes care.

In part 4 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the genesis of Watson and the work currently in the pipeline.

In part 5 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the findings from the cardiovascular study for use in Watson.

In part 6 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about her desire to make the healthcare system work more effectively and improve the practice of medicine.

In part 7, the conclusion of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the Watson tools available and how to access them.

It was about 22 years ago that I first hooked up with our publisher, Steve Freed. I had gotten involved with a nutritional multilevel company that had a soluble fiber product with two patents for lower serum cholesterol, and could level blood sugars. As you know, in an MLM company, …

By Sheri R. Colberg, PhD, FACSM

Whether you have type 1 or type 2 diabetes, if you use insulin, you may choose to use a specialized insulin pump for both your basal and bolus insulin delivery. Pumps have a small catheter placed under your skin and are programmed to cover your basal insulin needs by delivering small doses of fast-acting insulin to mimic normal insulin release by the pancreas. Insulin pumps are programmed to deliver small, basal doses of fast-acting insulin to mimic normal insulin release by the pancreas throughout the day. These pumps are not ideal for everyone, and the choice to use one should be an individual one.

Change in albuminuria as a surrogate endpoint for progression of chronic kidney disease strongly supported by biological plausibility, but empirical evidence to support validity in epidemiological studies still lacking.

Study aims to determine whether exercise training at two distinct times of day would have differing effects on 24-hour glucose levels in men with type 2 diabetes.

Trial assesses cardiovascular benefit in patients with diabetes.